EP1773822 - HETEROCYCLYLS AS SELECTIVE MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 23.04.2010 Database last updated on 03.09.2024 | Most recent event Tooltip | 07.10.2011 | Lapse of the patent in a contracting state New state(s): CY, TR | published on 09.11.2011 [2011/45] | Applicant(s) | For all designated states Schering Corporation 2000 Galloping Hill Road Kenilworth, NJ 07033-0530 / US | [2009/25] |
Former [2007/16] | For all designated states SCHERING CORPORATION 2000 Galloping Hill Road Kenilworth, NJ 07033-0530 / US | Inventor(s) | 01 /
SU, Jing 1398 Graymill Drive Scotch Plains, NJ 07076 / US | 02 /
MCKITTRICK, Brian 14 Millbrook Road New Vernon, NJ 07976 / US | 03 /
TANG, Haiqun 5 Waters Lane Belle Meade, NJ 08502 / US | 04 /
SASIKUMAR, Thavalakulamgara, K. 21 Canterbury Lane Edison, NJ 08820 / US | 05 /
QIANG, Li 261 Horizon Drive Edison, NJ 08817 / US | [2007/16] | Representative(s) | Adams, Harvey Vaughan John, et al Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB | [N/P] |
Former [2007/16] | Adams, Harvey Vaughan John, et al Mathys & Squire 120 Holborn London EC1N 2SQ / GB | Application number, filing date | 05773671.2 | 14.07.2005 | [2007/16] | WO2005US25060 | Priority number, date | US20040588492P | 16.07.2004 Original published format: US 588492 P | [2007/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2006019957 | Date: | 23.02.2006 | Language: | EN | [2006/08] | Type: | A2 Application without search report | No.: | EP1773822 | Date: | 18.04.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.02.2006 takes the place of the publication of the European patent application. | [2007/16] | Type: | B1 Patent specification | No.: | EP1773822 | Date: | 17.06.2009 | Language: | EN | [2009/25] | Search report(s) | International search report - published on: | EP | 27.04.2006 | Classification | IPC: | C07D409/12, C07D409/14, C07D417/12, C07D487/08 | [2007/16] | CPC: |
C07D487/08 (EP,US);
A61P3/04 (EP);
A61P3/06 (EP);
A61P3/10 (EP);
A61P43/00 (EP);
A61P5/50 (EP);
A61P9/12 (EP);
C07D277/26 (EP,US);
C07D277/28 (EP,US);
C07D333/20 (EP,US);
C07D409/12 (EP,US);
C07D409/14 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/16] | Extension states | AL | 16.02.2007 | BA | 16.02.2007 | HR | 16.02.2007 | MK | 16.02.2007 | YU | 16.02.2007 | Title | German: | HETEROCYCLYLVERBINDUNGEN ALS SELEKTIVE ANTAGONISTEN AM REZEPTOR FÜR DAS MELANINKONZENTRIERENDE HORMON ZUR BEHANDLUNG VON OBESITAS UND VERWANDTEN ERKRANKUNGEN | [2007/16] | English: | HETEROCYCLYLS AS SELECTIVE MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS | [2007/16] | French: | HETEROCYCLYLES UTILISES EN TANT QU'ANTAGONISTES DU RECEPTEUR DE L'HORMONE CONCENTRANT LA MELANINE POUR LE TRAITEMENT DE L'OBESITE ET DE TROUBLES ASSOCIES | [2008/52] |
Former [2007/16] | NOUVEAUX HETEROCYCLYLES UTILISES EN TANT QU'ANTAGONISTES DU RECEPTEUR DE L'HORMONE CONCENTRANT LA MELANINE POUR LE TRAITEMENT DE L'OBESITE ET DE TROUBLES ASSOCIES | Entry into regional phase | 16.02.2007 | National basic fee paid | 16.02.2007 | Designation fee(s) paid | 16.02.2007 | Examination fee paid | Examination procedure | 16.02.2007 | Examination requested [2007/16] | 03.08.2007 | Despatch of a communication from the examining division (Time limit: M06) | 16.01.2008 | Reply to a communication from the examining division | 25.08.2008 | Despatch of a communication from the examining division (Time limit: M04) | 11.11.2008 | Reply to a communication from the examining division | 15.12.2008 | Communication of intention to grant the patent | 15.04.2009 | Fee for grant paid | 15.04.2009 | Fee for publishing/printing paid | Opposition(s) | 18.03.2010 | No opposition filed within time limit [2010/21] | Fees paid | Renewal fee | 04.07.2007 | Renewal fee patent year 03 | 27.03.2008 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 17.06.2009 | BE | 17.06.2009 | CY | 17.06.2009 | CZ | 17.06.2009 | DK | 17.06.2009 | EE | 17.06.2009 | FI | 17.06.2009 | LT | 17.06.2009 | LV | 17.06.2009 | PL | 17.06.2009 | RO | 17.06.2009 | SI | 17.06.2009 | SK | 17.06.2009 | TR | 17.06.2009 | IE | 14.07.2009 | LU | 14.07.2009 | CH | 31.07.2009 | LI | 31.07.2009 | MC | 31.07.2009 | BG | 17.09.2009 | SE | 17.09.2009 | GR | 18.09.2009 | IS | 17.10.2009 | PT | 17.10.2009 | HU | 18.12.2009 | [2011/44] |
Former [2011/32] | AT | 17.06.2009 | |
BE | 17.06.2009 | ||
CZ | 17.06.2009 | ||
DK | 17.06.2009 | ||
EE | 17.06.2009 | ||
FI | 17.06.2009 | ||
LT | 17.06.2009 | ||
LV | 17.06.2009 | ||
PL | 17.06.2009 | ||
RO | 17.06.2009 | ||
SI | 17.06.2009 | ||
SK | 17.06.2009 | ||
IE | 14.07.2009 | ||
LU | 14.07.2009 | ||
CH | 31.07.2009 | ||
LI | 31.07.2009 | ||
MC | 31.07.2009 | ||
BG | 17.09.2009 | ||
SE | 17.09.2009 | ||
GR | 18.09.2009 | ||
IS | 17.10.2009 | ||
PT | 17.10.2009 | ||
HU | 18.12.2009 | ||
Former [2011/22] | AT | 17.06.2009 | |
BE | 17.06.2009 | ||
CZ | 17.06.2009 | ||
DK | 17.06.2009 | ||
EE | 17.06.2009 | ||
FI | 17.06.2009 | ||
LT | 17.06.2009 | ||
LV | 17.06.2009 | ||
PL | 17.06.2009 | ||
RO | 17.06.2009 | ||
SI | 17.06.2009 | ||
SK | 17.06.2009 | ||
IE | 14.07.2009 | ||
LU | 14.07.2009 | ||
CH | 31.07.2009 | ||
LI | 31.07.2009 | ||
MC | 31.07.2009 | ||
BG | 17.09.2009 | ||
SE | 17.09.2009 | ||
GR | 18.09.2009 | ||
IS | 17.10.2009 | ||
PT | 17.10.2009 | ||
Former [2011/01] | AT | 17.06.2009 | |
BE | 17.06.2009 | ||
CZ | 17.06.2009 | ||
DK | 17.06.2009 | ||
EE | 17.06.2009 | ||
FI | 17.06.2009 | ||
LT | 17.06.2009 | ||
LV | 17.06.2009 | ||
PL | 17.06.2009 | ||
RO | 17.06.2009 | ||
SI | 17.06.2009 | ||
SK | 17.06.2009 | ||
IE | 14.07.2009 | ||
CH | 31.07.2009 | ||
LI | 31.07.2009 | ||
MC | 31.07.2009 | ||
BG | 17.09.2009 | ||
SE | 17.09.2009 | ||
GR | 18.09.2009 | ||
IS | 17.10.2009 | ||
PT | 17.10.2009 | ||
Former [2010/40] | AT | 17.06.2009 | |
BE | 17.06.2009 | ||
CZ | 17.06.2009 | ||
DK | 17.06.2009 | ||
EE | 17.06.2009 | ||
FI | 17.06.2009 | ||
LT | 17.06.2009 | ||
LV | 17.06.2009 | ||
PL | 17.06.2009 | ||
RO | 17.06.2009 | ||
SI | 17.06.2009 | ||
SK | 17.06.2009 | ||
IE | 14.07.2009 | ||
CH | 31.07.2009 | ||
LI | 31.07.2009 | ||
MC | 31.07.2009 | ||
BG | 17.09.2009 | ||
SE | 17.09.2009 | ||
IS | 17.10.2009 | ||
PT | 17.10.2009 | ||
Former [2010/24] | AT | 17.06.2009 | |
BE | 17.06.2009 | ||
CZ | 17.06.2009 | ||
DK | 17.06.2009 | ||
EE | 17.06.2009 | ||
FI | 17.06.2009 | ||
LT | 17.06.2009 | ||
LV | 17.06.2009 | ||
PL | 17.06.2009 | ||
RO | 17.06.2009 | ||
SI | 17.06.2009 | ||
SK | 17.06.2009 | ||
CH | 31.07.2009 | ||
LI | 31.07.2009 | ||
MC | 31.07.2009 | ||
BG | 17.09.2009 | ||
SE | 17.09.2009 | ||
IS | 17.10.2009 | ||
PT | 17.10.2009 | ||
Former [2010/20] | AT | 17.06.2009 | |
BE | 17.06.2009 | ||
CZ | 17.06.2009 | ||
DK | 17.06.2009 | ||
EE | 17.06.2009 | ||
FI | 17.06.2009 | ||
LT | 17.06.2009 | ||
LV | 17.06.2009 | ||
PL | 17.06.2009 | ||
RO | 17.06.2009 | ||
SI | 17.06.2009 | ||
SK | 17.06.2009 | ||
MC | 31.07.2009 | ||
BG | 17.09.2009 | ||
SE | 17.09.2009 | ||
IS | 17.10.2009 | ||
PT | 17.10.2009 | ||
Former [2010/17] | AT | 17.06.2009 | |
BE | 17.06.2009 | ||
CZ | 17.06.2009 | ||
EE | 17.06.2009 | ||
FI | 17.06.2009 | ||
LT | 17.06.2009 | ||
LV | 17.06.2009 | ||
PL | 17.06.2009 | ||
RO | 17.06.2009 | ||
SI | 17.06.2009 | ||
SK | 17.06.2009 | ||
MC | 31.07.2009 | ||
BG | 17.09.2009 | ||
SE | 17.09.2009 | ||
IS | 17.10.2009 | ||
PT | 17.10.2009 | ||
Former [2010/12] | AT | 17.06.2009 | |
BE | 17.06.2009 | ||
CZ | 17.06.2009 | ||
EE | 17.06.2009 | ||
FI | 17.06.2009 | ||
LT | 17.06.2009 | ||
LV | 17.06.2009 | ||
PL | 17.06.2009 | ||
RO | 17.06.2009 | ||
SI | 17.06.2009 | ||
SK | 17.06.2009 | ||
MC | 31.07.2009 | ||
SE | 17.09.2009 | ||
IS | 17.10.2009 | ||
Former [2010/01] | AT | 17.06.2009 | |
FI | 17.06.2009 | ||
LT | 17.06.2009 | ||
LV | 17.06.2009 | ||
PL | 17.06.2009 | ||
SI | 17.06.2009 | ||
SE | 17.09.2009 | ||
Former [2009/52] | AT | 17.06.2009 | |
FI | 17.06.2009 | ||
LT | 17.06.2009 | ||
LV | 17.06.2009 | ||
SI | 17.06.2009 | ||
SE | 17.09.2009 | Cited in | International search | [A]WO02057233 (SCHERING CORP [US]) [A] 1 * the whole document * * Example 27, Ar3 means arylene *; | [DX]WO03047568 (SCHERING CORP [US]) [DX] 1-48 * examples 2,12-91,94-144,153-194,196-224,226-424; tables 1b,2 *; | [AP]WO2005034947 (SCHERING CORP [US], et al) [AP] 1-48* claims 1-26 *; | [X] - BROWNING A, "Recent developments in the discovery of melanin-concentrating hormone antagonists: Novel antiobesity agents", EXPERT OPINION ON THERAPEUTIC PATENTS 2004 UNITED KINGDOM, (2004), vol. 14, no. 3, ISSN 1354-3776, pages 313 - 325, XP002365091 [X] 1-48 * abstract * DOI: http://dx.doi.org/10.1517/13543776.14.3.313 |